Literature DB >> 20331568

The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007.

Amanda Roxburgh1, Wayne D Hall, Louisa Degenhardt, Jennifer McLaren, Emma Black, Jan Copeland, Richard P Mattick.   

Abstract

AIMS: To examine trends in patterns of cannabis use and related harm in the Australian population between 1993 and 2007.
DESIGN: Analysis of prospectively collected data from: (1) the National Drug Strategy Household Survey (NDSHS) and Australian Secondary Student Alcohol and Drug Survey (ASSADS); (2) the National Hospital Morbidity Database (NHMD); and (3) the Alcohol and Other Drug Treatment Services National Minimum Dataset (AODTS-NMDS). PARTICIPANTS: Australians aged 14 years and over from the general population; students aged 12-17 years; public and private hospital in-patients; public and private in-patients and out-patients attending for drug treatment. MEASUREMENT: Prevalence of 12-month cannabis use among the general population and secondary students. Proportions in the general population by age group reporting: daily cannabis use; difficulties in controlling cannabis use; and heavy cannabis use on each occasion. Number of hospital and treatment presentations for cannabis-related problems.
FINDINGS: Prevalence of past-year cannabis use has declined in the Australian population since the late 1990s. Among those reporting past-year use, daily use is prevalent among 40-49-year-olds, while heavy patterns of use are prevalent among 14-19-year-olds. Hospital presentations for cannabis-related problems reflect similar trends. Past-year cannabis use has decreased among the 10-19-year age group, but those who are daily users in this age group report using large quantities of cannabis.
CONCLUSIONS: Despite declines in the prevalence of cannabis use, continued public health campaigns warning of the harms associated with cannabis use are essential, aimed particularly at users who are already experiencing problems. The increasing demand for treatment for cannabis problems in Australia suggests the need for more accessible and more effective interventions for cannabis use disorders.

Entities:  

Mesh:

Year:  2010        PMID: 20331568     DOI: 10.1111/j.1360-0443.2010.02903.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  10 in total

1.  Natural course of cannabis use disorders.

Authors:  R F Farmer; D B Kosty; J R Seeley; S C Duncan; M T Lynskey; P Rohde; D N Klein; P M Lewinsohn
Journal:  Psychol Med       Date:  2014-05-12       Impact factor: 7.723

2.  The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age.

Authors:  Sharon R Sznitman
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-10       Impact factor: 4.035

Review 3.  Evidence for Sex Convergence in Prevalence of Cannabis Use: A Systematic Review and Meta-Regression.

Authors:  Cath Chapman; Tim Slade; Wendy Swift; Katherine Keyes; Zoe Tonks; Maree Teesson
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

4.  Age, period and cohort trends in drug abuse hospitalizations within the total Swedish population (1975-2010).

Authors:  Giuseppe N Giordano; Henrik Ohlsson; Kenneth S Kendler; Marilyn A Winkleby; Kristina Sundquist; Jan Sundquist
Journal:  Drug Alcohol Depend       Date:  2013-11-19       Impact factor: 4.492

5.  Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences.

Authors:  Alexander Wong; Kirily Keats; Kieron Rooney; Callum Hicks; David J Allsop; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

6.  Trends in cannabis use and attitudes toward legalization and use among Australians from 2001-2016: an age-period-cohort analysis.

Authors:  Navdep Kaur; Katherine M Keyes; Ava D Hamilton; Cath Chapman; Michael Livingston; Tim Slade; Wendy Swift
Journal:  Addiction       Date:  2020-10-07       Impact factor: 6.526

7.  Drug, sex and age differentials in the use of Australian publicly funded treatment services.

Authors:  Jane Anne Fischer; Alexandra Marie Clavarino; Jackob Moses Najman
Journal:  Subst Abuse       Date:  2012-03-07

8.  Who seeks treatment for cannabis use? Registered characteristics and physical, psychological and psychosocial problem indicators among cannabis patients and matched controls.

Authors:  Solveig Glestad Christiansen; Anne Line Bretteville-Jensen
Journal:  BMC Public Health       Date:  2018-06-22       Impact factor: 3.295

9.  Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms.

Authors:  Natasha Y Sheikhan; Ashlyn M Pinto; Dominik A Nowak; Farbod Abolhassani; Patrick Lefebvre; Mei Sheng Duh; Theodore J Witek
Journal:  JAMA Netw Open       Date:  2021-07-01

10.  Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile.

Authors:  Wendy Swift; Alex Wong; Kong M Li; Jonathon C Arnold; Iain S McGregor
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.